Investors & Media

SEC Filings

Document Details

Filing Date
April 6, 2022
Document Date
May 18, 2022
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com